0
     

Report Added
Report already added
Generic Injectable Drugs Market - Global Outlook and Forecast 2021-2027

Generic Injectable Drugs Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Generic Injectable Drugs in Global, including the following market information:
Global Generic Injectable Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Generic Injectable Drugs market was valued at 30440 million in 2020 and is projected to reach US$ 34720 million by 2027, at a CAGR of 3.3% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Generic Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Generic Injectable Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Generic Injectable Drugs Market Segment Percentages, By Type, 2020 (%)
Small Molecule
Large Molecule

China Generic Injectable Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Generic Injectable Drugs Market Segment Percentages, By Application, 2020 (%)
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases

Global Generic Injectable Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Generic Injectable Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Generic Injectable Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Generic Injectable Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
1 Introduction to Research & Analysis Reports
1.1 Generic Injectable Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic Injectable Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Generic Injectable Drugs Overall Market Size
2.1 Global Generic Injectable Drugs Market Size: 2021 VS 2027
2.2 Global Generic Injectable Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Generic Injectable Drugs Players in Global Market
3.2 Top Global Generic Injectable Drugs Companies Ranked by Revenue
3.3 Global Generic Injectable Drugs Revenue by Companies
3.4 Top 3 and Top 5 Generic Injectable Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Generic Injectable Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Generic Injectable Drugs Players in Global Market
3.6.1 List of Global Tier 1 Generic Injectable Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Generic Injectable Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Generic Injectable Drugs Market Size Markets, 2021 & 2027
4.1.2 Small Molecule
4.1.3 Large Molecule
4.2 By Type - Global Generic Injectable Drugs Revenue & Forecasts
4.2.1 By Type - Global Generic Injectable Drugs Revenue, 2016-2021
4.2.2 By Type - Global Generic Injectable Drugs Revenue, 2022-2027
4.2.3 By Type - Global Generic Injectable Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Generic Injectable Drugs Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Anesthesia
5.1.4 Anti-Infectives
5.1.5 Parenteral Nutrition
5.1.6 Cardiovascular Diseases
5.2 By Application - Global Generic Injectable Drugs Revenue & Forecasts
5.2.1 By Application - Global Generic Injectable Drugs Revenue, 2016-2021
5.2.2 By Application - Global Generic Injectable Drugs Revenue, 2022-2027
5.2.3 By Application - Global Generic Injectable Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Generic Injectable Drugs Market Size, 2021 & 2027
6.2 By Region - Global Generic Injectable Drugs Revenue & Forecasts
6.2.1 By Region - Global Generic Injectable Drugs Revenue, 2016-2021
6.2.2 By Region - Global Generic Injectable Drugs Revenue, 2022-2027
6.2.3 By Region - Global Generic Injectable Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Generic Injectable Drugs Revenue, 2016-2027
6.3.2 US Generic Injectable Drugs Market Size, 2016-2027
6.3.3 Canada Generic Injectable Drugs Market Size, 2016-2027
6.3.4 Mexico Generic Injectable Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Generic Injectable Drugs Revenue, 2016-2027
6.4.2 Germany Generic Injectable Drugs Market Size, 2016-2027
6.4.3 France Generic Injectable Drugs Market Size, 2016-2027
6.4.4 U.K. Generic Injectable Drugs Market Size, 2016-2027
6.4.5 Italy Generic Injectable Drugs Market Size, 2016-2027
6.4.6 Russia Generic Injectable Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Generic Injectable Drugs Market Size, 2016-2027
6.4.8 Benelux Generic Injectable Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Generic Injectable Drugs Revenue, 2016-2027
6.5.2 China Generic Injectable Drugs Market Size, 2016-2027
6.5.3 Japan Generic Injectable Drugs Market Size, 2016-2027
6.5.4 South Korea Generic Injectable Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Generic Injectable Drugs Market Size, 2016-2027
6.5.6 India Generic Injectable Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Generic Injectable Drugs Revenue, 2016-2027
6.6.2 Brazil Generic Injectable Drugs Market Size, 2016-2027
6.6.3 Argentina Generic Injectable Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Generic Injectable Drugs Revenue, 2016-2027
6.7.2 Turkey Generic Injectable Drugs Market Size, 2016-2027
6.7.3 Israel Generic Injectable Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Generic Injectable Drugs Market Size, 2016-2027
6.7.5 UAE Generic Injectable Drugs Market Size, 2016-2027
7 Players Profiles
7.1 Hospira (Pfizer Inc.)
7.1.1 Hospira (Pfizer Inc.) Corporate Summary
7.1.2 Hospira (Pfizer Inc.) Business Overview
7.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Major Product Offerings
7.1.4 Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue in Global (2016-2021)
7.1.5 Hospira (Pfizer Inc.) Key News
7.2 Fresenius Kabi
7.2.1 Fresenius Kabi Corporate Summary
7.2.2 Fresenius Kabi Business Overview
7.2.3 Fresenius Kabi Generic Injectable Drugs Major Product Offerings
7.2.4 Fresenius Kabi Generic Injectable Drugs Revenue in Global (2016-2021)
7.2.5 Fresenius Kabi Key News
7.3 Sandoz (Novartis)
7.3.1 Sandoz (Novartis) Corporate Summary
7.3.2 Sandoz (Novartis) Business Overview
7.3.3 Sandoz (Novartis) Generic Injectable Drugs Major Product Offerings
7.3.4 Sandoz (Novartis) Generic Injectable Drugs Revenue in Global (2016-2021)
7.3.5 Sandoz (Novartis) Key News
7.4 Hikma Pharmaceuticals PLC
7.4.1 Hikma Pharmaceuticals PLC Corporate Summary
7.4.2 Hikma Pharmaceuticals PLC Business Overview
7.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Major Product Offerings
7.4.4 Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue in Global (2016-2021)
7.4.5 Hikma Pharmaceuticals PLC Key News
7.5 Dr. Reddy’s Laboratories Ltd
7.5.1 Dr. Reddy’s Laboratories Ltd Corporate Summary
7.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
7.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Major Product Offerings
7.5.4 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue in Global (2016-2021)
7.5.5 Dr. Reddy’s Laboratories Ltd Key News
7.6 Grifols
7.6.1 Grifols Corporate Summary
7.6.2 Grifols Business Overview
7.6.3 Grifols Generic Injectable Drugs Major Product Offerings
7.6.4 Grifols Generic Injectable Drugs Revenue in Global (2016-2021)
7.6.5 Grifols Key News
7.7 Nichi-Iko Group (Sagent)
7.7.1 Nichi-Iko Group (Sagent) Corporate Summary
7.7.2 Nichi-Iko Group (Sagent) Business Overview
7.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Major Product Offerings
7.4.4 Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue in Global (2016-2021)
7.7.5 Nichi-Iko Group (Sagent) Key News
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Corporate Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Generic Injectable Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Generic Injectable Drugs Revenue in Global (2016-2021)
7.8.5 Teva Pharmaceutical Key News
7.9 Auromedics
7.9.1 Auromedics Corporate Summary
7.9.2 Auromedics Business Overview
7.9.3 Auromedics Generic Injectable Drugs Major Product Offerings
7.9.4 Auromedics Generic Injectable Drugs Revenue in Global (2016-2021)
7.9.5 Auromedics Key News
7.10 Sanofi
7.10.1 Sanofi Corporate Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Generic Injectable Drugs Major Product Offerings
7.10.4 Sanofi Generic Injectable Drugs Revenue in Global (2016-2021)
7.10.5 Sanofi Key News
7.11 Gland Pharma
7.11.1 Gland Pharma Corporate Summary
7.11.2 Gland Pharma Business Overview
7.11.3 Gland Pharma Generic Injectable Drugs Major Product Offerings
7.11.4 Gland Pharma Generic Injectable Drugs Revenue in Global (2016-2021)
7.11.5 Gland Pharma Key News
7.12 Endo International PLC
7.12.1 Endo International PLC Corporate Summary
7.12.2 Endo International PLC Business Overview
7.12.3 Endo International PLC Generic Injectable Drugs Major Product Offerings
7.12.4 Endo International PLC Generic Injectable Drugs Revenue in Global (2016-2021)
7.12.5 Endo International PLC Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Generic Injectable Drugs Market Opportunities & Trends in Global Market
Table 2. Generic Injectable Drugs Market Drivers in Global Market
Table 3. Generic Injectable Drugs Market Restraints in Global Market
Table 4. Key Players of Generic Injectable Drugs in Global Market
Table 5. Top Generic Injectable Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Generic Injectable Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Generic Injectable Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Generic Injectable Drugs Product Type
Table 9. List of Global Tier 1 Generic Injectable Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Generic Injectable Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Generic Injectable Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Generic Injectable Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Generic Injectable Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Generic Injectable Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Generic Injectable Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Generic Injectable Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Generic Injectable Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Generic Injectable Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Generic Injectable Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Generic Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Generic Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Generic Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Generic Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Generic Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Generic Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Generic Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Generic Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Generic Injectable Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Generic Injectable Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Hospira (Pfizer Inc.) Corporate Summary
Table 31. Hospira (Pfizer Inc.) Generic Injectable Drugs Product Offerings
Table 32. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Fresenius Kabi Corporate Summary
Table 34. Fresenius Kabi Generic Injectable Drugs Product Offerings
Table 35. Fresenius Kabi Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Sandoz (Novartis) Corporate Summary
Table 37. Sandoz (Novartis) Generic Injectable Drugs Product Offerings
Table 38. Sandoz (Novartis) Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Hikma Pharmaceuticals PLC Corporate Summary
Table 40. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Offerings
Table 41. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Dr. Reddy’s Laboratories Ltd Corporate Summary
Table 43. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product Offerings
Table 44. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Grifols Corporate Summary
Table 46. Grifols Generic Injectable Drugs Product Offerings
Table 47. Grifols Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Nichi-Iko Group (Sagent) Corporate Summary
Table 49. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Offerings
Table 50. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Teva Pharmaceutical Corporate Summary
Table 52. Teva Pharmaceutical Generic Injectable Drugs Product Offerings
Table 53. Teva Pharmaceutical Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Auromedics Corporate Summary
Table 55. Auromedics Generic Injectable Drugs Product Offerings
Table 56. Auromedics Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Generic Injectable Drugs Product Offerings
Table 59. Sanofi Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 60. Gland Pharma Corporate Summary
Table 61. Gland Pharma Generic Injectable Drugs Product Offerings
Table 62. Gland Pharma Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)
Table 63. Endo International PLC Corporate Summary
Table 64. Endo International PLC Generic Injectable Drugs Product Offerings
Table 65. Endo International PLC Generic Injectable Drugs Revenue (US$, Mn), (2016-2021)

List of Figures
Figure 1. Generic Injectable Drugs Segment by Type
Figure 2. Generic Injectable Drugs Segment by Application
Figure 3. Global Generic Injectable Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Generic Injectable Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Generic Injectable Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Generic Injectable Drugs Revenue in 2020
Figure 8. By Type - Global Generic Injectable Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Generic Injectable Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Generic Injectable Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Generic Injectable Drugs Revenue Market Share, 2016-2027
Figure 12. US Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Generic Injectable Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Generic Injectable Drugs Revenue Market Share, 2016-2027
Figure 24. China Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Generic Injectable Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Generic Injectable Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Generic Injectable Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Fresenius Kabi Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sandoz (Novartis) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Grifols Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Teva Pharmaceutical Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Auromedics Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Sanofi Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Gland Pharma Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Report Title: Generic Injectable Drugs Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW